BioSpace News Archive

Business

Aerie Pharmaceuticals Announces Appointment of Damien Monaghan, Quality Director

Aerie Pharmaceuticals, Inc. today announced the appointment of Damien Monaghan, Quality Director, reporting to Finbar O’Neill, EU Director, Quality & Regulatory Compliance.

September 24, 2018
·
7 min read
Policy

Epizyme Announces the U.S. Food and Drug Administration Lifts Partial Clinical Hold on Tazemetostat Clinical Program

Investor Conference Call Scheduled for Today at 8:30 a.m. EDT

September 24, 2018
·
5 min read
Business

Former “Yo-Yo Dieter” Launches Funny, Unfiltered Blog on Weight-loss Surgery

Jennifer Harmon has had it with obesity. After years of failed diets and unflattering photos, she still had more questions than answers about surgical weight-loss options, so she launched a blog called Confessions of a Yo-Yo Dieter.

September 24, 2018
·
1 min read
Biotech Beach

AmpliPhi Biosciences to Present Clinical Case Series Data at IDWeek 2018

Professor Jonathan Iredell to present data from AmpliPhi Biosciences’ ongoing expanded access program for bacteriophage product candidates AB-SA01 (targeting S. aureus) and AB-PA01 (targeting P. aeruginosa)

September 24, 2018
·
2 min read
Business

Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low- and Middle-Income Countries

Mylan N.V. and medical device company Atomo Diagnostics today announced a strategic partnership to commercialize CE-Marked in vitro HIV rapid diagnostic tests for self-testing in low- and middle-income countries.

September 24, 2018
·
7 min read
Deals

CenTrak Bolsters Security Solutions offering through Elpas Acquisition

Market leading IoT provider expands Security Solutions portfolio and international presence via acquisition of select assets of Elpas from Johnson Controls

September 24, 2018
·
2 min read
Drug Development

Alexion Announces Successful Phase 3 PREVENT Study of Soliris® (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Soliris® Reduced the Risk of Adjudicated On-Trial Relapse by 94.2% Compared to Placebo (p < 0.0001).

September 24, 2018
·
17 min read
FDA

Boston Scientific Receives U.S. FDA Approval for the Eluvia™ Drug-Eluting Vascular Stent System

First peripheral vascular interventional technology approved in the U.S. to offer sustained release of antiproliferative drug to treat patients with peripheral artery disease

September 24, 2018
·
6 min read
Policy

Another exciting step towards legalization: Tweed Retail is Coming to Manitoba!

Canopy Growth Corporation is pleased to announce that it has completed the required Cannabis Retail Organization Agreement and Cannabis Store Retailer Agreements with the Manitoba Government and today unveiled the future locations of its first Tweed retail sites in the province.

September 24, 2018
·
5 min read
Business

Weight Watchers Becomes WW, Reinforcing Its Mission to Focus on Overall Health and Wellbeing

Introduces New Tagline: “Wellness That Works.TM”

September 24, 2018
·
6 min read